Agile Therapeutics Inc. announced the launch of the women’s healthcare company’s first consumer commercial intended to increase awareness of the Twirla weekly birth control patch.
Nine Biotechs Facing FDA Decisions in December 2017
Active Psoriatic Arthritis (PsA), Biopharma, Biosimilars, Biotech, Breast Cancer, Chronic Myeloid Leukemia (CML), Contraceptives, FDA, FDA/Regulatory, Glucagon-Like Peptide-1 (GLP-1) Analogs, Growth Hormone Deficiency (GHD), Hormonal Contraceptive Patches, New Drug Application (NDA), New Drug Applications, OTC, Patches, PDUFA, Supplemental Biologics License Application (sBLA), Supplemental New Drug Application (sNDA), Supplemental New Drug Application (sNDA), Type 2 DiabetesThe biopharma industry and the U.S. Food and Drug Administration face a busy December with nine companies awaiting approval decisions.